check_circleStudy Completed

Fever, Migraine, Pain

BAY81-8781, Single dose escalation study

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

18 - 45 Years
  • -

  • -

Trial summary

Enrollment Goal
38
Trial Dates
July 2010 - December 2010
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Aspirin (Acetylsalicylic Acid, BAY81-8781)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Bayer HealthCareWuppertal, 42096, Germany

Trial design

Single dose escalation study to investigate safety, tolerability and pharmacokinetics of increasing inhalative doses of Acetylsalicylic Acid (BAY 81-8781) in a randomized, singleblind, group-comparison design in healthy male subjects
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A